Barcelona: Parkinson’s Treatments on the Horizon
With effective symptomatic treatments in hand, many Parkinson’s researchers have now set their sights on loftier goals...
6397 RESULTS
Sort By:
With effective symptomatic treatments in hand, many Parkinson’s researchers have now set their sights on loftier goals...
For Parkinson’s disease, unlike Alzheimer’s, physicians have numerous effective treatments to reduce symptoms and improve their patients’ quality of life...
Suggesting that oxidative stress precipitates cell death in neurodegenerative disease is one thing; proving it is quite another...
Biomarkers could be invaluable diagnostic and prognostic indicators for Alzheimer’s and other neurodegenerative diseases...
Indications are that amyloid-β destroys memory by disrupting synaptic plasticity...
As the research field’s collective eyes are shifting toward the γ-secretase modulators, what do scientists actually have on that score?...
Researchers have been pushing genomewide association studies as a means to find genetic variants that put people at risk for AD...
Have amyloid researchers had the formula for graceful aging and no neurodegeneration under their microscopes all along?...
Scientists appear to be losing faith in the concept of Notch-sparing γ-secretase inhibition...
Whatever happened to BACE inhibitors?...
Dementia with Lewy bodies (DLB) sits at the interface of several disorders...
The common late-onset forms of Alzheimer’s and Parkinson’s disease are now believed to involve substantial inherited risk...
Scientists are becoming increasingly aware of what Parkinson’s disease does to the mind...
Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field Barcelona: Straight Talk From a Regulator on Trials in Parkinson’s Barcelona: Taking Parkinson’s Research From Movement to Mind Barcelona: What Lies Beyond Genomewide Association Studies? Barc
Researchers report that tau is acetylated in vitro, in cell culture, in a mouse tauopathy model, and in several human tauopathies...